ASX - By Stock
|
KZA |
Re:
Ann: Trading Halt
|
|
novogenbuyer
|
22 |
8.3K |
8 |
14/01/23 |
14/01/23 |
ASX - By Stock
|
22
|
8.3K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Trading Halt
|
|
novogenbuyer
|
22 |
8.3K |
6 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
22
|
8.3K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Trading Halt
|
|
novogenbuyer
|
22 |
8.3K |
9 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
22
|
8.3K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
novogenbuyer
|
48 |
14K |
6 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
48
|
14K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Interim data from MSKCC study
|
|
novogenbuyer
|
47 |
21K |
5 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
47
|
21K
|
5
|
|
ASX - By Stock
|
KZA |
Is 15.7 months mOS good enough for GBM? Can it be statistically significant?
|
|
novogenbuyer
|
3 |
1.5K |
12 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
3
|
1.5K
|
12
|
|
ASX - By Stock
|
KZA |
Re:
Its a dead duck
|
|
novogenbuyer
|
69 |
24K |
9 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
69
|
24K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Change in substantial holding
|
|
novogenbuyer
|
3 |
1.3K |
5 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
3
|
1.3K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Memorial Sloan Results Imminent
|
|
novogenbuyer
|
80 |
30K |
9 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
80
|
30K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
Ann: GBM Agile Update
|
|
novogenbuyer
|
178 |
64K |
4 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
178
|
64K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: GBM Agile Update
|
|
novogenbuyer
|
178 |
64K |
5 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
178
|
64K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: GBM Agile Update
|
|
novogenbuyer
|
178 |
64K |
9 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
178
|
64K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
Ann: GBM Agile Update
|
|
novogenbuyer
|
178 |
64K |
7 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
178
|
64K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Ann: GBM Agile Update
|
|
novogenbuyer
|
178 |
64K |
1 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
178
|
64K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: GBM Agile Update
|
|
novogenbuyer
|
178 |
64K |
4 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
178
|
64K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: GBM Agile Update
|
|
novogenbuyer
|
178 |
64K |
4 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
178
|
64K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: GBM Agile Update
|
|
novogenbuyer
|
178 |
64K |
11 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
178
|
64K
|
11
|
|
ASX - By Stock
|
KZA |
Re:
Memorial Sloan Results Imminent
|
|
novogenbuyer
|
80 |
30K |
13 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
80
|
30K
|
13
|
|
ASX - By Stock
|
KZA |
Re:
Simcere Therapeutics
|
|
novogenbuyer
|
2 |
1.0K |
10 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
2
|
1.0K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia launches new SAB
|
|
novogenbuyer
|
56 |
15K |
6 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
56
|
15K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia launches new SAB
|
|
novogenbuyer
|
56 |
15K |
13 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
56
|
15K
|
13
|
|
ASX - By Stock
|
KZA |
Re:
RPDD - priorty review vouchers
|
|
novogenbuyer
|
13 |
3.6K |
8 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
13
|
3.6K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia progress update
|
|
novogenbuyer
|
38 |
11K |
16 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
38
|
11K
|
16
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Change in substantial holding
|
|
novogenbuyer
|
55 |
13K |
2 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
55
|
13K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Change in substantial holding
|
|
novogenbuyer
|
55 |
13K |
3 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
55
|
13K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Change in substantial holding
|
|
novogenbuyer
|
55 |
13K |
2 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
55
|
13K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
novogenbuyer
|
559 |
157K |
6 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
559
|
157K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
novogenbuyer
|
559 |
157K |
5 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
559
|
157K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
novogenbuyer
|
559 |
157K |
10 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
559
|
157K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Application for quotation of securities - KZA
|
|
novogenbuyer
|
9 |
3.9K |
17 |
19/06/22 |
19/06/22 |
ASX - By Stock
|
9
|
3.9K
|
17
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Application for quotation of securities - KZA
|
|
novogenbuyer
|
9 |
3.9K |
13 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
9
|
3.9K
|
13
|
|
ASX - By Stock
|
KZA |
Re:
News: KZA Kazia Says Phase II Study Of Paxalisib In Brain Metastases Advances To Expansion Stage In...
|
|
novogenbuyer
|
17 |
5.2K |
11 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
17
|
5.2K
|
11
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Proposed issue of securities - KZA
|
|
novogenbuyer
|
23 |
6.3K |
7 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
23
|
6.3K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
novogenbuyer
|
2.0K |
625K |
10 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
2.0K
|
625K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
novogenbuyer
|
57 |
16K |
7 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
57
|
16K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia establishes ATM program
|
|
novogenbuyer
|
42 |
13K |
6 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
42
|
13K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia establishes ATM program
|
|
novogenbuyer
|
42 |
13K |
0 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
42
|
13K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
novogenbuyer
|
2.0K |
625K |
7 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
2.0K
|
625K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Kazia Share Price
|
|
novogenbuyer
|
791 |
220K |
6 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
791
|
220K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia releases final data from P2 paxalisib trial
|
|
novogenbuyer
|
107 |
33K |
17 |
10/12/21 |
10/12/21 |
ASX - By Stock
|
107
|
33K
|
17
|
|
ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
novogenbuyer
|
559 |
157K |
2 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
559
|
157K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
novogenbuyer
|
559 |
157K |
2 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
559
|
157K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
novogenbuyer
|
559 |
157K |
3 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
559
|
157K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
novogenbuyer
|
559 |
157K |
4 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
559
|
157K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia releases final data from P2 paxalisib trial
|
|
novogenbuyer
|
107 |
33K |
19 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
107
|
33K
|
19
|
|
ASX - By Stock
|
KZA |
Re:
Data
|
|
novogenbuyer
|
14 |
4.4K |
10 |
05/12/21 |
05/12/21 |
ASX - By Stock
|
14
|
4.4K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia releases final data from P2 paxalisib trial
|
|
novogenbuyer
|
107 |
33K |
10 |
04/12/21 |
04/12/21 |
ASX - By Stock
|
107
|
33K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
Priscilla Brastianos to present at Miami Brain Symposium
|
|
novogenbuyer
|
8 |
2.5K |
11 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
8
|
2.5K
|
11
|
|
ASX - By Stock
|
KZA |
Re:
Priscilla Brastianos to present at Miami Brain Symposium
|
|
novogenbuyer
|
8 |
2.5K |
22 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
8
|
2.5K
|
22
|
|
ASX - By Stock
|
KZA |
Priscilla Brastianos to present at Miami Brain Symposium
|
|
novogenbuyer
|
8 |
2.5K |
11 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
8
|
2.5K
|
11
|
|